BBU: Brookfield Business Partners LP Kelajakdagi narxning foydaga nisbati
Brookfield kam baholangan aktivlarni sotib olish va samarali boshqaruvni joriy qilish orqali o'zining sanoat portfelini kengaytirmoqda. Kompaniyaning joriy forward P/E koeffitsiyenti ushbu jarayonlar dinamikasini aks ettiradi, bunda 12.90 joriy parametr qiymati vazifasini bajaradi. Ushbu o'sish kirish to'siqlari yuqori bo'lgan optimallashtirilgan bizneslarni qayta sotishga asoslangan Private Equity modeliga tayanadi va boshqaruvning restrukturizatsiya bo'yicha chuqur ekspertizasi bilan qo'llab-quvvatlanadi.
Brookfield kompaniyasining tahliliy kesimlari
- kotirovkalar va tahlilchilar prognozi:
- bozor kapitallashuvi haqida ma'lumot:
- balans bo'yicha xususiy kapital ma'lumotlari:
- qarz yuki va likvidlik ko'rsatkichlari:
Qarzning xususiy kapitalga nisbati Brookfield|BBU - Uzoq muddatli qarzning kapitalga nisbati|Qisqa muddatli qarzning kapitalga nisbati Brookfield|BBU - Kompaniyaning jamlangan qarzdorligi|Balans kapitallashuviga qarzlar Brookfield Business Partners L.P.|BBU - Uzoq muddatli qarz hajmi|Kompaniyaning qisqa muddatli qarzlari Brookfield Business Partners|Tezkor likvidlik bbu.brookfield.com
- kompaniyaning daromadliligi va baholash multiplikatorlari ko'rsatkichlari:
BBU - Kompaniyaning sof foydasi|Prognoz qilingan kelajakdagi foyda Brookfield|BBU - Narx-foyda multiplikatori|Forvard P/E multiplikatori Brookfield|BBU - Narxning foydaga va o‘sish sur’atiga nisbati|EV/EBITDA multiplikatori Brookfield Business Partners L.P.|BBU - Foizlar, soliqlar va eskirish to'lanishidan oldingi foyda|So'nggi 12 oy davomida bir aksiya uchun sof foyda Brookfield Business Partners|BBU - Bir aksiya uchun sof foyda (EPS TTM)|Choraklik EPS foyda o'sishi bbu.brookfield.com|BBU - Joriy yilda bir aksiya uchun foyda ortishi|Keyingi yil uchun bir aksiya uchun sof foyda o'sishi prognozi Brookfield
Kompaniyaning fundamental baholanishi:Brookfield Business Partners
Brookfield (BBU) marja masshtabini kengaytirish samaradorligi sotib olingan sanoat aktivlarini muvaffaqiyatli restrukturizatsiya qilish va ularning xarajatlarini optimallashtirishga bog'liq. Kompaniyaning oldingi P/E koeffitsiyenti dinamikasini tahlil qilish orqali investorlar kutilayotgan daromadlar o'sishi uchun bozor premiumini baholaydilar, bunda sanoatga nisbatan shishirilgan baholashlar kapital xarajatlarining oshishi xavfi va holding kengayishi sekinlashgan taqdirda investitsiyalarning potensial to'xtashi signalini beradi.
Asosiy raqobatchilar
Forvard P/E multiplikatori BRK-A|Kelajakdagi narxning foydaga nisbati JNJ (Johnson and Johnson)|Kelajakdagi narxning foydaga nisbati General Electric GE|Kelajakdagi narx-foyda multiplikatori MMM|ITW - Kelajakdagi narxning foydaga nisbati|Prognoz qilingan narx-foyda nisbati orix.co.jp|Dover (DOV) - Kelajakdagi narxning foydaga nisbati|Prognoz qilingan narx-foyda nisbati Plains All American (PAGP)|Kelajakdagi narxning foydaga nisbati Kanzhun Ltd|Forvard P/E multiplikatori Liberty Broadband Corp.|Forvard P/E multiplikatori SWX|CSW: Narxning kutilayotgan foydaga nisbati|Forvard P/E multiplikatori GFF (Griffon)|Kapitalizatsiyaning prognoz qilingan foydaga nisbati Otter Tail Power Company (OTTR)|Brookfield Business Corp - Forvard P/E multiplikatori|Prognoz qilingan narx-foyda nisbati Pampa Energia S.A.|MDU Resources Group (MDU) - Kelajakdagi narxning foydaga nisbati|PCH (potlatchdeltic.com) - Kelajakdagi narxning foydaga nisbati|CSAN (Cosan) - Forvard P/E multiplikatori|Narxning kelajakdagi foydaga nisbati NWL (Newell Brands Inc)|Forvard P/E multiplikatori KEN|Kelajakdagi narxning foydaga nisbati FORTY (Formula Systems Group)|Forvard P/E multiplikatori TRS (TriMas Corporation)|ziffdavis.com - Kelajakdagi narxning foydaga nisbati|SPB: Prognoz qilingan narxning foydaga nisbati|TIPT - Forvard P/E multiplikatori|SOS: Forvard P/E multiplikatori|Resolute Group - Kelajakdagi narx-foyda multiplikatori|Kelajakdagi narxning foydaga nisbati Compass Diversified Corp|Prognoz qilingan narx-foyda nisbati valhi.net VHI|Kelajakdagi narxning foydaga nisbati Tejon Ranch (TRC)|Kelajakdagi narxning foydaga nisbati UPXI (Upexi Inc)|Forvard P/E multiplikatori BBCP (Concrete Pumping Holdings, Inc.)|PRTC: Narxning kelajakdagi foydaga nisbati|Babcock & Wilcox - Forvard P/E multiplikatori|Kapitalizatsiyaning prognoz qilingan foydaga nisbati NL Industries, Inc. NL|mercerint.com (MERC) - Kelajakdagi narxning foydaga nisbati|Narxning kelajakdagi foydaga nisbati LGO|GEG (Great Elm Group Inc) - Forvard P/E multiplikatori|VATE - Forvard narx-foyda multiplikatori|Forvard P/E multiplikatori MGLD|Kelajakdagi narxning foydaga nisbati STRR (starequity.com)|Kelajakdagi narxning foydaga nisbati United-Guardian UG|Kelajakdagi narx-foyda multiplikatori HTCR|NXPL - Kelajakdagi narxning foydaga nisbati|Prognoz qilingan narx-foyda nisbati Marwynn Holdings, Inc.|planetgreenholdings.com (PLAG) - Kelajakdagi narxning foydaga nisbati|Prognoz qilingan narx-foyda nisbati Document Security Systems (DSS)|Kelajakdagi narxning foydaga nisbati ARB IOT Group Limited|Forvard P/E multiplikatori newconceptenergy.com|Forvard P/E multiplikatori UK|HE: Narxning kutilayotgan foydaga nisbati|Forvard P/E multiplikatori AULT (Ault Alliance, Inc.)|Kapitalizatsiyaning prognoz qilingan foydaga nisbati cswindustrials.com (CSWI)|Ideanomics Corp - Forvard P/E multiplikatori|Prognoz qilingan narx-foyda nisbati Jewett-Cameron Trading Company Ltd|Steel Partners Holdings, L.P. (SPLP) - Kelajakdagi narxning foydaga nisbati|VGR (Vector Group) - Kelajakdagi narxning foydaga nisbati|VINO (Gaucho Group Holdings Inc.) - Forvard P/E multiplikatori|Narxning kelajakdagi foydaga nisbati RHLDV (composecure.com)
